Physician profile
Peter Fillerup
NPI 1366450405
$2,268.10
in general payments reported to CMS, 2019-2025
10 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.75 · 2022: $20.88 · 2023: $1,779 · 2024: $327 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151 · Travel and Lodging: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.25 |
| Travel and Lodging | $1,079.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,692.52 | 2023 | |
| Biotissue Holdings INC. | $257.04 | 2024 | |
| Cornerstone Medical Associates, INC. | $92.66 | 2023-2025 | |
| Organogenesis INC. | $91.43 | 2023-2025 | Nushield, Via Matrix, Puraply |
| Bone Support INC. | $32.84 | 2025 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $24.65 | 2025 | Nuzyra |
| Orthofix Medical, INC. | $23.84 | 2023 | Spinal-Stim, Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.88 | 2022 | |
| Merck Sharp & Dohme LLC | $16.75 | 2019 | |
| Mimedx Group, INC. | $15.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Fillerup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.